 |
|
|
| |
You are here: Home > News > Press Room >
Fact Sheet
|
| |
What is PNDRI?
Pacific Northwest Diabetes Research Institute is a cell biology research institute, specializing in diabetes. We were founded in 1956 by Dr. William B. Hutchinson, Sr., as the first private non-profit biomedical and clinical research institute in the Northwest. Our focus today is the prevention and cure of diabetes.
PNDRI Diabetes Research
PNDRI scientists investigate key problems in the diagnosis and treatment of diabetes. We study the genetic risk and environmental triggers of type 1 diabetes. Our scientists also investigate the effects of high glucose and fatty acids on the insulin system. Both of these play important roles in the development of type 2 diabetes and its complications. Two PNDRI labs are researching the growth and development of beta cells.
Scientists at PNDRI engage in clinical as well as basic research. Currently, we are working with other researchers on methods for preserving beta cell function. We also lead the Human Islet Transplantation Program in Seattle (HITS), studying ways to improve islet transplantation as an effective treatment for diabetes.
About the Institute
PNDRI employs more than 70 researchers in 7 investigative teams. Two of its principal scientists are members of the National Academy of Sciences. PNDRI collaborates actively with researchers around the world. Its results are highly regarded by peer scientists, and its work is supported by the most prestigious government and private funding agencies, including the National Institutes of Health, the National Cancer Institute, the Centers for Disease Control, the American Heart Association, and the American Diabetes Association.
JOIN US IN DISCOVERY:
On the path to cure and prevention
|
